HIV patients' gastrointestinal tolerability and treatment satisfaction after switching from lopinavir/ritonavir (LPV/r) SGC to co-formulated LPV/r tablets
| Autor: | Mde Castera, Joaquín Borrás-Blasco, Alberto Belda, J.D. Rosique-Robles, F.J. Abad |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Adult patients business.industry Public Health Environmental and Occupational Health Lopinavir/ritonavir Pharmacology Gastrointestinal tolerability Antidiarrheal Drugs Gastroenterology Treatment satisfaction Infectious Diseases Internal medicine medicine Hiv patients business medicine.drug |
| Zdroj: | Journal of the International AIDS Society. 11:P162 |
| ISSN: | 1758-2652 |
| DOI: | 10.1186/1758-2652-11-s1-p162 |
| Popis: | Methods Adult patients under LPV/r SGC Tx for at least 6 months, and with >95% adherence, were included. Following data were collected: overall GI side-effects; presence and gradation of diarrhea according to WHO severity scale; antidiarrheal drugs administration during the last month under LPV/r SGC Tx, and during 2nd and 6th month after switching to LPV/r tablets. Also, patient Tx satisfaction grade and preferences data were gathered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink